Gazyva contains Obinutuzumab, 1000mg/40mL, supplied as injection. Manufacturer: Roche. Therapeutic class: CD20 mAb (Type II).
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.